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Abstract
Takotsubo cardiomyopathy is a form of transient, reversible left ventricular dysfunction that can
mimic an acute coronary event. However, cardiac catheterization often reveals normal coronary
arteries. Patients are often postmenopausal women who experience acute physical or emotional
distress. The prognosis for this entity is quite favorable. In this report, we present three cases of
Takotsubo cardiomyopathy in patients having procedures involving anesthesia. Each case illustrates
a different etiology for the syndrome: Patient, procedure, and anesthetic management.
Background
Takotsubo cardiomyopathy, also known as the 'transient
left ventricular apical ballooning syndrome', is an uncom-
mon phenomenon originally described in the Japanese
population in 1991. [1] Sufferers are typically postmeno-
pausal women who experience acute physical or emo-
tional stress and subsequently develop chest pain and
dyspnea. [2] The pathophysiological mechanism is likely
catecholamine overload. [3]
Ventriculography typically reveals LV apical akinesis/
hypokinesis and basal hypercontractility. [4] This gives
the characteristic "takotsubo," or octopus trap appear-
ance. Ejection fraction is typically near 30% [3]. Coronary
angiography is typically unremarkable, as most patients
have no coronary artery disease, or non-obstructive dis-
ease [4]. Prognosis is generally favorable, as in-hospital
mortality was 1.1%, and recurrence 3.5% in a review of
multiple studies. [5] We present three cases of Takotsubo
cardiomyopathy occurring at our institution in the past six
months in patients having procedures involving anesthe-
sia. Each case illustrates a different etiology for the syn-
drome: Patient, procedure, and anesthetic management.
Case presentation
Case 1
A 71 year-old woman with a history of depression, refrac-
tory to medical management, presented with a major
depressive episode for electroconvulsive therapy (ECT).
She had an uneventful ECT series four years prior, consist-
ing of approximately 10 sessions. Her past medical history
was significant only for hypertension. Her medications
included daily quetiapine 300 mg, nortriptyline 25 mg,
metoprolol succinate 100 mg, amlodipine 5 mg, and ati-
van 0.5 mg. She was also taking a four-day course of
cefuroxime for a urinary tract infection. She had no aller-
gies, and no family history of heart disease. Her electrocar-
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diogram one day prior to ECT revealed normal sinus
rhythm, at 97 beats per minute, with no ST or T abnormal-
ities, or Q waves.
Anesthesia was induced with 50 mg of methohexitol, and
50 mg of succinylcholine. After unilateral ECT was deliv-
ered to the right side of the head, a generalized seizure was
initiated. The patient remained hemodynamically stable,
resumed spontaneous respirations, and emerged rapidly.
Three to four hours following the procedure she com-
plained of chest pain. Her ECG revealed T wave flattening
in AVL, and poor precordial R wave progression. A tro-
ponin level performed at that time was 3.28 ng/mL. Car-
diac catheterization revealed non-obstructive coronary
artery disease. Echocardiography demonstrated LV dys-
function with an ejection fraction of 20%, and a large api-
cal aneurysm. A follow up echocardiogram one day later
revealed improved LV function, and an EF of 45%. The
troponin levels decreased over seven days to 0.18 ng/mL.
Based on these results, the consulting cardiologist diag-
nosed Takotsubo cardiomyopathy. Subsequently, this
patient's blood pressure regimen was modified with the
addition of an angiotensin converting enzyme inhibitor.
Follow-up echocardiography four months later revealed
normal ejection fraction. Since that episode, the patient
has had nineteen uneventful follow-up ECT treatments.
These follow-up ECT treatments were performed with the
addition of nicardipine, esmolol, and/or labetolol for
blood pressure management, and cardioprotection.
Case 2
A 34 year-old woman with a history of asthma, hypercho-
lesterolemia, pregnancy associated hypertension, obesity,
and migraine headaches presented with a two week epi-
sode of post-prandial nausea, vomiting, and right-upper
quadrant pain. Cholelithiasis was diagnosed, and the
patient was scheduled for elective cholecystectomy. Her
medications included daily hydrochlorothiazide 25 mg,
rosuvastatin, montelukast sodium 10 mg, twice-daily flu-
ticasone/salmeterol 500/50, and a rarely used albuterol
metered-dose inhaler. She recently started celecoxib for
her abdominal pain. She had an allergy to simvastatin,
which was associated with a rash. She used no alcohol,
tobacco, or other drugs. Her family history was significant
only for hypertension.
Baseline vital signs included blood pressure 130/74, heart
rate 67, respiratory rate 16, and room air oxygen satura-
tion 98%. Exercise tolerance was not limited by chest pain
or dyspnea. Her physical exam was significant for obesity,
and tenderness to deep palpation of the right upper quad-
rant, without guarding, or rebound. Preoperative ECG
revealed normal sinus rhythm at 64 bpm, normal axis, T
inversion in II, III, and AVF, V3-6, with T flattening in V1-
2, ST depression of 1 mm in II, II, F, V3-6. A bedside tran-
sthoracic echocardiogram was performed in the preopera-
tive area, and was normal. The cardiologist performing
the exam felt that the patient was at very low risk for a cor-
onary event, despite the abnormal ECG, and insisted that
the patient was in optimal condition for the procedure.
In the operating room, the patient was given intravenous
midazolam 1 mg, and fentanyl 50 mcg, and pre-oxygena-
tion. Minutes later she developed pressure-like, non-radi-
ating, substernal chest pain, and dyspnea. She was noted
to be diaphoretic, tachypneic, and hypoxic, with an oxy-
gen saturation of 80–90%. Her first non-invasive blood
pressure reading was 213/141, with a heart rate in the
140s. Large ST elevations were noted on the 5-lead ECG
monitor in leads I, and AVL. Metoprolol 1 mg was given,
and the heart rate slowed to the 70s, with an unobtainable
blood pressure. Phenylephrine was given, an arterial line
was placed, and the initial blood pressure was 90/50. A
12-lead ECG was obtained and revealed new ST elevations
in I and AVL, and ST depressions in V4-6.
Surgery was cancelled, and the patient was transferred to
the intensive care unit. The initial troponin level was 0.4
ng/mL, and peaked at 9.0 within six hours. The patient
received oral aspirin 325 mg, clopidogrel 600 mg, and an
intravenous heparin drip. A repeat echocardiogram
revealed posterior wall akinesis, inferior wall hypokinesis,
and an EF of 35–40%. Cardiac catheterization was per-
formed the following day and revealed normal coronary
anatomy. Ventriculography showed findings consistent
with the preceding echocardiogram.
After an extensive workup, the patient was diagnosed with
Takotsubo cardiomyopathy, with the 0 possibility of
vasospastic angina.
A follow-up echocardiogram at one month revealed nor-
mal LV size, function, EF, and no wall motion abnormal-
ities. Three months later, the patient had an uneventful
laparoscopic cholecystectomy, having started atenolol
prior to the procedure.
Case 3
An 83 year-old woman with bilateral carotid stenosis pre-
sented for elective right carotid endarterectomy. Her past
medical history included hypertension, hypercholestero-
lemia, polymyalgia rheumatica, pernicious anemia, and
peptic ulcer disease treated with a Billroth 2 gastrectomy.
Her preoperative medications included olmesartan, alen-
dronate, rosuvastatin, and aspirin, which had been
stopped seven days prior to surgery. Of note, the patient
took olmesartan, an angiotensin receptor blocker, the
morning of surgery. She had no allergies, no history ofCases Journal 2008, 1:227 http://www.casesjournal.com/content/1/1/227
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smoking, alcohol consumption, or other drug use, and no
family history of heart disease.
Her preoperative ECG was significant for low-voltage
QRS. Her preoperative blood pressure was 97/58, heart
rate 93, respirations 15, and room air oxygen saturation
97%. Her chest was clear to auscultation bilaterally, heart
tones were normal, and there was no JVD. No medica-
tions were given in the preoperative area.
In the operating room, an IV and radial arterial line were
placed, and the patient was sedated with midazolam and
fentanyl. Anesthesia induction and intubation were facil-
itated with lidocaine, etomidate, and vecuronium. Prior
to induction, a phenylephrine drip had been started at 25
mcg/min to maintain systolic blood pressure greater than
150 mm Hg, a target requested by the neurosurgical
attending. During intubation, blood pressure briefly rose
to 220/100 with a heart rate of 100. Subsequently, during
dissection of the carotid sheath, blood pressure was noted
to be poorly responsive to phenylephrine boluses, how-
ever ephedrine was effective. At one point during dissec-
tion an episode of bradycardia and hypotension occurred
that was treated with 0.2 mg glycopyrrolate, 10 mg ephe-
drine, and 80 mcg phenylephrine simultaneously as the
surgeon's released manual pressure on the carotid sinus.
The heart rate quickly normalized, with recovery of blood
pressure to previous levels (SBP 140s).
During the following hour, maintaining the target blood
pressure became increasingly difficult, and was punctu-
ated by a series of transient precipitous drops, followed by
recovery with treatment. Vasopressin was given in two 0.5
unit boluses, with a 2 unit/hr infusion, followed by sev-
eral boluses of norepinephrine ranging from 8–32 mcg.
The phenylephrine infusion started at the beginning of
the case was titrated as high as 75 mcg/min, but was safely
discontinued upon release of the carotid cross clamp. The
procedure was nearing completion by the end of the hour,
and pink frothy fluid was noted in the gas sampling line.
Breath sounds were coarse, but not crackly. Oxygen satu-
ration fell to 95% at one point, but recovered to 97% fol-
lowing suctioning of the endotracheal tube. The patient
was deemed stable for extubation, and was transported to
the PACU on a 100% non-rebreather mask.
In the PACU, the patient complained of dull, non-radiat-
ing, substernal chest pain. The ECG revealed a low-voltage
QRS, but was essentially unchanged from baseline. A
chest x-ray revealed pulmonary edema. The troponin level
was 5.19 ng/mL. Cardiac catheterization revealed normal
coronary anatomy, ventriculography revealed severe ante-
rolateral hypokinesis, and severe apical septal hypokine-
sis, with a left-ventricular ejection fraction of 25%. Of
note, pulmonary capillary wedge pressure was 25 cm
H2O. An intra-aortic counterpulsation balloon pump was
placed for cardiogenic shock. The patient recovered in cor-
onary care unit (CCU), and was discharged one week
later. Follow-up studies cardiac studies were said to have
returned to normal.
Discussion
Takotsubo cardiomyopathy is most commonly associated
with acute physical or emotional stress. [2] Our cases are
unusual in that they were all associated with different
forms of iatrogenic stress related to medical procedures.
First, during the course of ECT treatment, it is common for
blood pressure and heart rate to increase because of
endogenous catecholamine release. Elevated catecho-
lamine levels are found within one minute and frequently
last 10–15 minutes [6,7]. However, there have been only
a few case reports of Takotsubo cardiomyopathy associ-
ated with ECT [8].
Second, while it is difficult to determine precisely the eti-
ology and sequence of pathological events in our second
case, the patient experienced an acutely stressful event,
and developed Takotsubo cardiomyopathy. Given this
history of migraine headaches, and sudden onset of the
episode, we feel it is most likely that this patient experi-
enced severe coronary vasospasm, which may have
resulted in ischemia, leading to myocardial dysfunction.
Alternatively, the emotional and physical stress of the cor-
onary vasospasm may have caused a surge in endogenous
catecholamines that was directly responsible for inducing
Takotsubo cardiomyopathy, as diagnosed by the cardiol-
ogist.
Third, the catecholamine excess that led to Takotsubo car-
diomyopathy was iatrogenic. To optimize collateral circu-
lation to the brain during carotid cross-clamping,
anesthesiologists frequently induce hypertension. Our
patient was particularly resistant to the usual doses of phe-
nylephrine, a pure alpha-1 vasoconstrictor. We attributed
this to preoperative treatment of her hypertension with an
angiotensin receptor blocker (ARB), which has been asso-
ciated with enhanced and potentially severe hypotension
during anesthesia. [6,7] Her blood pressure did respond
to ephedrine, an indirect inotrope-vasoconstrictor. She
received a total of 50 mg ephedrine over the first hour of
surgery. The phenylephrine, ephedrine, norepinephrine
and vasopressin likely all contributed to the patient devel-
oping Takotsubo cardiomyopathy, and ultimately heart
failure. The most effective treatment for anesthesia-
induced ARB/ACE-I hypotension is terlipressin. [8,9] In
this case, vasopressin was given in two small boluses, and
an infusion was started. At the same time, several boluses
of norepinephrine were given. These treatments werePublish with BioMed Central    and   every 
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minimally effective, because she was likely already in
heart failure.
Takotsubo cardiomyopathy is an increasingly reported
phenomenon that may occur not only in settings of acute
physical or emotional stress, but also iatrogenic stress
related to common medical procedures. Physicians partic-
ipating in these procedures would be well advised to con-
sider the risk factors inherent in the patient, procedure,
and anesthetic management for developing this syn-
drome, in order to better anticipate and potentially pre-
vent this outcome.
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